Trials / Unknown
UnknownNCT02823548
Primary Care Study With Chondroitin Sulfate and Glucosamine Hydrochloride in Hand Osteoarhritis
Double-blind, Randomised, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of the Combination of Chondroitin Sulphate and Glucosamine Hydrochloride in Patients With Hand Osteoarthritis
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 330 (estimated)
- Sponsor
- Bioiberica · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
PICASSO has been designed to demonstrate that combination therapy with CS/GH has superior efficacy compared to placebo in pain reduction (average score reduction in Huskisson's 0 to 100 mm Visual Analogue Scale) from baseline to 6 months of treatment in patients with symptomatic hand osteoarthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Droglican | Chondroitin Sulfate 1,200mg + Glucosamine Hydrochloride 1,500mg |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-06-01
- Completion
- 2017-07-01
- First posted
- 2016-07-06
- Last updated
- 2016-11-11
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02823548. Inclusion in this directory is not an endorsement.